ArticleFrontiers in pharmacology2023

Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.

Can G Leineweber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.